Laxman Nallan

Author PubWeight™ 12.12^‹?›

Top papers

Rank	Title	Journal	Year	PubWeight™‹?›
1	Second generation tetrahydroquinoline-based protein farnesyltransferase inhibitors as antimalarials.	J Med Chem	2007	1.60
2	Efficacy, pharmacokinetics, and metabolism of tetrahydroquinoline inhibitors of Plasmodium falciparum protein farnesyltransferase.	Antimicrob Agents Chemother	2007	1.43
3	Cytosolic phospholipase A2-alpha is necessary for platelet-activating factor biosynthesis, efficient neutrophil-mediated bacterial killing, and the innate immune response to pulmonary infection: cPLA2-alpha does not regulate neutrophil NADPH oxidase activity.	J Biol Chem	2004	1.22
4	Oncogenic action of secreted phospholipase A2 in prostate cancer.	Cancer Res	2004	1.21
5	Resistance to a protein farnesyltransferase inhibitor in Plasmodium falciparum.	J Biol Chem	2005	1.18
6	Pathway-oriented profiling of lipid mediators in macrophages.	Biochem Biophys Res Commun	2005	1.05
7	Discovery of selective aminothiazole aurora kinase inhibitors.	ACS Chem Biol	2008	1.00
8	Golgi-associated cPLA2alpha regulates endothelial cell-cell junction integrity by controlling the trafficking of transmembrane junction proteins.	Mol Biol Cell	2009	0.95
9	Expression of phospholipases A2 in primary human lung macrophages: role of cytosolic phospholipase A2-alpha in arachidonic acid release and platelet activating factor synthesis.	Biochim Biophys Acta	2008	0.88
10	Group IVC cytosolic phospholipase A2gamma is farnesylated and palmitoylated in mammalian cells.	J Lipid Res	2005	0.82
11	Polychlorinated biphenyls induce arachidonic acid release in human platelets in a tamoxifen sensitive manner via activation of group IVA cytosolic phospholipase A2-alpha.	Biochem Pharmacol	2005	0.78